EYA inhibitors constitute a chemically heterogeneous class of compounds that have garnered attention due to their capacity to modulate the activity of the Eyes Absent (EYA) family of proteins. These inhibitors operate through intricate mechanisms involving specific binding interactions with discrete sites on EYA proteins, resulting in the perturbation of their enzymatic functions and regulatory roles in diverse cellular processes. EYA proteins, recognized for their multifunctional nature, exert influence over pivotal biological phenomena, encompassing embryonic development, DNA repair, and intricate cell signaling pathways. EYA inhibitors function as intricately designed molecular entities with a pronounced focus on disrupting the inherent catalytic activities and intricate functional associations of EYA proteins. The catalytic activities of EYA proteins, integral to their physiological roles, are harnessed by EYA inhibitors' deliberate interference. By interacting with EYA proteins in a selective manner, these inhibitors induce conformational changes that hold the ability to reverberate throughout downstream signaling cascades and cellular responses.
The realm of EYA inhibitors encompasses a spectrum of compounds spanning the gamut from naturally derived to synthetic, each endowed with a unique structural framework that underlies their selective interaction with EYA proteins. The diversity in the chemical makeup of these inhibitors permits tailored targeting of distinct facets of EYA protein functionality. The evolving landscape of EYA inhibitor research is poised to unravel the intricacies underpinning the inhibitory mechanisms, shed light on the precise molecular interactions governing the inhibitor-protein interplay, and decipher the implications of EYA protein targeting within an array of biological contexts. This unfolding comprehension has the ability to enrich our understanding of fundamental cellular processes while also offering prospects for future applications that extend beyond the confines of the cell.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Benzbromarone | 3562-84-3 | sc-233934 sc-233934A | 1 g 5 g | $52.00 $219.00 | ||
Originally developed as a uricosuric agent, benzbromarone has shown inhibitory effects on EYA proteins. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
A natural isoflavone found in soy products, genistein has been studied for its anti-cancer properties and its ability to inhibit EYA proteins. | ||||||
Thiolutin | 87-11-6 | sc-200387 sc-200387A | 1 mg 5 mg | $99.00 $398.00 | 1 | |
THL is a natural product with EYA inhibitory properties. It has been investigated for its potential in cancer therapy due to its ability to disrupt EYA-mediated oncogenic pathways. | ||||||